Right to Try Act of 2017-S.204 and H.R.878- 115th Congress -2017-2018
The Right To Try act was approved in the United States Senate.
The idea is to remove obstacles set up by the Food and Drug Administration that some say may prevent pharmaceutical companies from initiating or expanding compassionate care programs. The bill’s aim is to require the federal government to allow manufacturing and access to treat a patient with a terminal illness. In these cases, the drug is already approved under state law and was restricted by the FDA. The federal government will allow use of these treatments if a patient’s physician states and certifies that they first tried all other treatment options.
I also stated at a meeting that 38 states adopted the Right To Try act and this created momentum for the discussion of the Right To Try act in The house of Representatives and the Senate. Some patient advocacy groups are against this bill so it might be changed a bit in the House.
– Mike Sosna